Positron Stock Price, News & Analysis

Positron Corporation (OTC: POSC) has been awarded the Innovation Award in the PET-CT Imaging category at the 2025 Medical Device Network Excellence Awards. The company's PET-CT 64 Slice system stands out as the most cost-effective PET-CT system in the US, making advanced hybrid imaging more accessible to smaller clinics and community hospitals.

The system offers significant advantages including enhanced workflow efficiency with capability to perform up to 20+ exams daily, flexible rental packages, and comprehensive clinical applications across cardiac, oncology, and neurology imaging. Positron plans to launch its advanced Affinity 4D PET-CT system in Q4 2025, featuring LYSO crystal technology, AI-enhanced motion monitoring, and improved dose reduction techniques.

Positron Corporation (OTC: POSC), a molecular imaging technology leader, has announced two strategic corporate developments. The company has established a new corporate headquarters in the Buffalo-Niagara Falls region under a long-term lease, which will serve as their corporate operations hub, product showroom, and testing center.

Additionally, Positron's Board of Directors has approved the company's redomiciling from Texas to Delaware. This move aims to enhance corporate governance and legal framework as the company prepares to file a Form 10 registration statement with the SEC to become a fully reporting public company.

Positron Corporation (OTC: POSC) has secured a significant sale of four PET-CT 64-slice scanners to a leading nuclear cardiology group. The company's next-generation imaging systems feature a 72 cm wide-bore gantry, high-sensitivity detectors with reduced radiation exposure, and the smallest footprint in its class.

The PET-CT scanners deliver high-resolution anatomic and functional imaging for both cardiac and oncology applications, offering enhanced diagnostic capabilities from myocardial perfusion to tumor detection. The deal highlights growing market acceptance of Positron's advanced imaging technology and comprehensive support services.

Positron Corporation (OTC: POSC) has announced the sale of its NeuSight PET-CT 64-slice scanner to a prominent nuclear cardiologist. The NeuSight PET-CT scanner features a 72 cm gantry and high-sensitivity acquisition technology that reduces radiation exposure. The system, which has the smallest footprint in its class, is designed for both cardiology and oncology applications, offering anatomic and functional imaging capabilities.

The scanner supports various studies, including cardiac, tumor, and neurological imaging. According to President Adel Abdullah, this sale to a key opinion leader (KOL) of a larger medical group represents a potential gateway to broader organizational opportunities as Positron expands into the western U.S. market.

Positron (OTC: POSC) has announced the sale of four PET-CT scanners to a prominent cardiovascular diagnostics provider. The company's molecular imaging systems feature a 72 cm gantry and high-sensitivity acquisition technology, reducing radiation exposure while maintaining compact design.

The PET-CT systems are engineered for both cardiology and oncology applications, offering advanced data acquisition capabilities for faster and more precise scans. Key features include the smallest footprint in their class, versatility for cardiac and tumor imaging, and brain studies capabilities.

According to Adel Abdullah, President of Positron, this sale reflects growing demand for cardiac PET imaging. The company aims to make PET technology more accessible through cost-effective solutions and comprehensive support services.

Positron (POSC) has secured an $8 million equity investment through the sale of 8 million common shares to two strategic investors. The capital will fund the company's expansion in the PET-CT imaging market, particularly in nuclear cardiology and oncology.

The funding will support multiple strategic initiatives, including:

• Enhanced sales and marketing efforts
• Expansion of sales personnel
• Product development and offerings
• Strengthening industry partnerships
• Market expansion in North America and Europe

The company plans to use this capital to resume SEC filings and pursue an uplisting to a senior stock exchange. According to President Adel Abdullah, this investment positions Positron to capitalize on increasing PET-CT imaging adoption and develop a competitive edge in the marketplace.

Positron (OTC: POSC) has secured an agreement for three NeuSight PET-CT 64-slice scanners under its Prime Rental Program with a leading cardiovascular practice. The NeuSight PET-CT features a 72 cm gantry and high-sensitivity acquisition technology, offering reduced radiation exposure and superior imaging capabilities.

The system boasts the smallest footprint among PET-CT systems and excels in both cardiology and oncology studies. Key features include advanced data acquisition technology for faster and more precise scans, supporting various molecular imaging applications including heart, tumor, and brain studies.

Positron (OTC: POSC) has announced the sale of its Attrius PET and NeuSight PET-CT 64 slice nuclear imaging systems to a prominent cardiology specialist. The Attrius, a 2D quantitative dedicated PET scanner, provides high-resolution images and blood flow data for coronary flow reserve analysis. The NeuSight PET-CT features a spacious 72 cm gantry and high-sensitivity acquisition technology, reducing radiation exposure while maintaining superior imaging capabilities.

The NeuSight PET-CT system, notable for its smallest footprint and lightest weight in its class, supports both cardiology and oncology applications. It enables faster, more precise scans for heart, tumor, and brain studies. The company's president, Adel Abdullah, highlighted these sales as indicators of growing market momentum and emphasized their technology's role in advancing PET imaging and cardiovascular care.

Positron (OTC: POSC) has announced a significant business agreement for its NeuSight PET-CT scanners, securing deals for four sales and four rentals of their 64-slice systems to a prominent cardiovascular diagnostics provider. The NeuSight PET-CT scanner features a spacious 72 cm gantry and high-sensitivity acquisition technology, reducing radiation exposure while maintaining superior imaging quality.

The system stands out for having the smallest footprint and lightest weight in its category, while offering advanced capabilities for both cardiology and oncology applications. The technology enables faster and more precise scans, supporting various molecular imaging applications including heart, tumor, and brain studies. The company's offering includes comprehensive clinical support and training through their network of industry-leading physicians.